Clinical Trials Directory

Trials / Completed

CompletedNCT03946553

The Dysbiosis of the Intestinal Microbiota in Individuals With Allergic Rhinitis (MICRORIN)

The Dysbiosis of the Intestinal Microbiota in Individuals With Allergic Rhinitis: an Observational Study (MICRORIN)

Status
Completed
Phase
Study type
Observational
Enrollment
51 (actual)
Sponsor
Technological Centre of Nutrition and Health, Spain · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Allergic rhinitis (AR) is triggered by environmental allergens such as pollen and mites, and is associated with several symptoms such as itching and nasal congestion, sneezing or tearing and redness of the eyes. RA can affect patients life quality who suffer it, reducing the quality of sleep and cognitive function, causing irritability and fatigue and, consequently a decrease in work performance. Because the existing pharmacological treatments for RA are not entirely effective, it is of interest to find other means to enhance the effects of these drugs and decrease more effectively the signs and symptoms associated with RA. In this context, RA has been related to an alteration of the intestinal microbiota (MI).However, there is a need to characterize in detail the MI of individuals who suffer RA. The main objective of the present study is to characterize the MI of individuals with RA, compared with people without RA. In addition, the secondary objective is to study the association between characteristics of the MI of individuals with RA and different immunological markers.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention

Timeline

Start date
2019-05-17
Primary completion
2019-06-21
Completion
2019-06-21
First posted
2019-05-10
Last updated
2022-02-28

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03946553. Inclusion in this directory is not an endorsement.